Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri, United States of America.
PLoS One. 2013 Jun 14;8(6):e66434. doi: 10.1371/journal.pone.0066434. Print 2013.
This study examined the effects of BMP7 gene transfer on corneal wound healing and fibrosis inhibition in vivo using a rabbit model. Corneal haze in rabbits was produced with the excimer laser performing -9 diopters photorefractive keratectomy. BMP7 gene was introduced into rabbit keratocytes by polyethylimine-conjugated gold nanoparticles (PEI2-GNPs) transfection solution single 5-minute topical application on the eye. Corneal haze and ocular health in live animals was gauged with stereo- and slit-lamp biomicroscopy. The levels of fibrosis [α-smooth muscle actin (αSMA), F-actin and fibronectin], immune reaction (CD11b and F4/80), keratocyte apoptosis (TUNEL), calcification (alizarin red, vonKossa and osteocalcin), and delivered-BMP7 gene expression in corneal tissues were quantified with immunofluorescence, western blotting and/or real-time PCR. Human corneal fibroblasts (HCF) and in vitro experiments were used to characterize the molecular mechanism mediating BMP7's anti-fibrosis effects. PEI2-GNPs showed substantial BMP7 gene delivery into rabbit keratocytes in vivo (2×10(4) gene copies/ug DNA). Localized BMP7 gene therapy showed a significant corneal haze decrease (1.68±0.31 compared to 3.2±0.43 in control corneas; p<0.05) in Fantes grading scale. Immunostaining and immunoblot analyses detected significantly reduced levels of αSMA (46±5% p<0.001) and fibronectin proteins (48±5% p<0.01). TUNEL, CD11b, and F4/80 assays revealed that BMP7 gene therapy is nonimmunogenic and nontoxic for the cornea. Furthermore, alizarin red, vonKossa and osteocalcin analyses revealed that localized PEI2-GNP-mediated BMP7 gene transfer in rabbit cornea does not cause calcification or osteoblast recruitment. Immunofluorescence of BMP7-transefected HCFs showed significantly increased pSmad-1/5/8 nuclear localization (>88%; p<0.0001), and immunoblotting of BMP7-transefected HCFs grown in the presence of TGFβ demonstrated significantly enhanced pSmad-1/5/8 (95%; p<0.001) and Smad6 (53%, p<0.001), and decreased αSMA (78%; p<0.001) protein levels. These results suggest that localized BMP7 gene delivery in rabbit cornea modulates wound healing and inhibits fibrosis in vivo by counter balancing TGFβ1-mediated profibrotic Smad signaling.
本研究通过兔模型考察了 BMP7 基因转染对角膜创伤愈合和抑制纤维化的影响。采用准分子激光行-9 屈光度光折射性角膜切削术在兔角膜上造成角膜混浊。通过聚乙烯亚胺偶联的金纳米粒子(PEI2-GNPs)转染液单次 5 分钟眼部局部应用将 BMP7 基因导入兔角膜细胞。通过体视显微镜和裂隙灯生物显微镜评估活体动物的角膜混浊和眼部健康状况。用免疫荧光、Western blot 和/或实时 PCR 定量分析角膜组织中纤维化水平[α-平滑肌肌动蛋白(αSMA)、F-肌动蛋白和纤维连接蛋白]、免疫反应(CD11b 和 F4/80)、角膜细胞凋亡(TUNEL)、钙化(茜素红、von Kossa 和骨钙素)和递送的 BMP7 基因表达。用人角膜成纤维细胞(HCF)和体外实验来表征介导 BMP7 抗纤维化作用的分子机制。PEI2-GNPs 在体内向兔角膜细胞中显著递呈 BMP7 基因(2×10(4)基因拷贝/μg DNA)。局部 BMP7 基因治疗在 Fantes 分级量表中显示出明显降低的角膜混浊度(与对照组相比,1.68±0.31 与 3.2±0.43;p<0.05)。免疫染色和免疫印迹分析检测到 αSMA 蛋白水平显著降低(46±5%,p<0.001)和纤维连接蛋白蛋白水平显著降低(48±5%,p<0.01)。TUNEL、CD11b 和 F4/80 检测表明 BMP7 基因治疗对角膜无免疫原性和毒性。此外,茜素红、von Kossa 和骨钙素分析表明,兔角膜中局部 PEI2-GNP 介导的 BMP7 基因转移不会导致钙化或成骨细胞募集。转染 BMP7 的 HCF 的免疫荧光显示 Smad-1/5/8 核定位显著增加(>88%;p<0.0001),在 TGFβ 存在下培养的转染 BMP7 的 HCF 的免疫印迹显示 pSmad-1/5/8 显著增强(95%;p<0.001)和 Smad6(53%,p<0.001),αSMA 蛋白水平显著降低(78%;p<0.001)。这些结果表明,兔角膜局部 BMP7 基因转导通过平衡 TGFβ1 介导的促纤维化 Smad 信号转导来调节伤口愈合并抑制体内纤维化。